EDUCATING LEADERS IN PHARMACY AND PHARMACEUTICAL SCIENCES SINCE 1886
The Drug Overdose Epidemic: Harm Reduction and the Role of the Pharmacist
Online home study activity
Start date: August 19, 2024
End date: August 31, 2025
Target Audience
Pharmacists in all practice settings and other clinical health care providers
Why you should attend
Pharmacists are among the most accessible healthcare providers in the United States and are uniquely positioned to provide harm reduction services. Pharmacists are considered underutilized health providers. This training provides an overview of the role of the pharmacist in harm reduction as well as practices for providing harm reduction services. This course will identify barriers to implementing these services and highlight strategies for pharmacists to implement these services.
On this page:
Learning Objectives
- Describe harm reduction strategies for the pharmacist such as naloxone, syringe access and disposal, and buprenorphine and the NY Public Health Laws that support them.
- Identify barriers that limit access to harm reduction interventions and strategies to create a welcoming environment for people who use drugs (PWUD).
- Identify emerging drug trends, changes in buprenorphine regulations and the role of pharmacists to address them.
Program Schedule
This activity contains a pre-test, educational material, educational video, a post-test, and a program evaluation. Successful achievement of this activity requires achieving a score of 70% or higher on the post-test.
Requirements for Obtaining Continuing Education Credit
Participants must take the activity pre-test, but there is no minimum score required. A score of 70% or greater on the activity post-test is required to obtain continuing education credit.
Presenters
Karl Williams, JD, MBA, MS, BS Pharm
Professor of Pharmacy Ethics and Law
St. John Fisher University, Wegmans School of Pharmacy
Christopher Woodring, PharmD
Director, Pharmacy Operations
Trillium Health
Program Cost
There is no fee for this program and there is no commercial support associated with this educational activity. This program is supported by the Overdose Data to Action grant from the New York State Department of Health.
Financial Support
This program did not receive any external financial support.
Technical Requirements
Recommended web browsers:
Firefox, version 111 (64-bit) or higher
Chrome, version 109 (64 bit) or higher
Due to security issues with Internet Explorer, we only recommend using one of the browsers listed above.
How to enable cookies:
Firefox
Chrome
Minimum recommended system requirements:
Internet Speed: 5 Mbps
Processor: Dual-core 2Ghz or higher
Memory (RAM): 8GB
Storage: Storage requirements are minimal unless materials are downloaded.
Disclosure Declaration
ACPE is committed to ensuring that accredited continuing education (1) presents learners with only accurate, balanced, and scientifically justified recommendations, and (2) protects learners from promotion, marketing, and commercial bias. The individuals involved with the planning and presentation of this activity have the following financial relationships to disclose:
Faculty Disclosures:
Karl Williams, JD, MBA, MS, BS Pharm has nothing to disclose
Christopher Woodring, PharmD has nothing to disclose
Planning Committee Disclosures:
Lisa Skill, MS, MCHES has nothing to disclose
Clara DeSanctis, MPH has nothing to disclose
Piper Coalson, GCPH has nothing to disclose
Accreditation Information
The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been accredited as a knowledge-based activity. Credit will be uploaded to the CPE Monitor to those who complete all components of this activity. No partial credit is available.
ACPE # 0044-0000-24-022-H08-P, 1.5 contact hours, 0.15 CEU
Questions?
Please email pharmacyce@buffalo.edu